Range
7.41 - 7.88
Vol / Avg.
17.1K/109.9K
Div / Yield
-
52 Wk
7.09 - 16.23
Mkt Cap
328M
Payout Ratio
-
Open
7.73
P/E
-
EPS
0
Shares
42.2M
Outstanding
42.2M
Total Float
-
Benzinga - Jul 6, 2021, 10:16AM
Benzinga - Jul 6, 2021, 7:52AM
Benzinga - Jul 6, 2021, 7:05AM
Benzinga - Jun 16, 2021, 10:28AM
Benzinga - Jun 16, 2021, 10:16AM
Benzinga - Jun 16, 2021, 10:03AM
Benzinga - Nov 17, 2020, 9:19AM
Benzinga - Nov 11, 2020, 10:45AM
Benzinga - Nov 11, 2020, 10:44AM
Benzinga - Nov 11, 2020, 8:09AM
load more
Sector: Health Care.Industry: Biotechnology
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.

Earnings

see more
FY 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-10
REV
H1 2022Est.ActualSurprise
EPS
(EXPECTED)2021-08-10
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
OPTOpthea-0.64%328M

Opthea Frequently Asked Questions

Q

How do I buy Opthea (OPT) stock?

A

You can purchase shares of Opthea (NASDAQ: OPT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Opthea's (OPT) competitors?

A

Other companies in Opthea’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Aeglea BioTherapeutics (NASDAQ:AGLE), Fortress Biotech (NASDAQ:FBIO), CytomX Therapeutics (NASDAQ:CTMX) and 89bio (NASDAQ:ETNB).

Q

What is the target price for Opthea (OPT) stock?

A

The latest price target for Opthea (NASDAQ: OPT) was reported by Citigroup on November 17, 2020. The analyst firm set a price target for 48.00 expecting OPT to rise to within 12 months (a possible 517.76% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Opthea (OPT)?

A

The stock price for Opthea (NASDAQ: OPT) is $7.77 last updated Today at 8:00:02 PM.

Q

Does Opthea (OPT) pay a dividend?

A

There are no upcoming dividends for Opthea.

Q

When is Opthea (NASDAQ:OPT) reporting earnings?

A
Opthea’s FY earnings are confirmed for after-market on August 10, 2021.
Q

Is Opthea (OPT) going to split?

A

There is no upcoming split for Opthea.

Q

What sector and industry does Opthea (OPT) operate in?

A

Opthea is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.